Cargando…
Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
BACKGROUND: Combined treatment with anthracyclines (e.g., doxorubicin; Dox) and trastuzumab (Trz), a humanized anti-human epidermal growth factor receptor 2 (HER2; ErbB2) antibody, in patients with HER2-positive cancer is limited by cardiotoxicity, as manifested by contractile dysfunction and arrhyt...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058443/ https://www.ncbi.nlm.nih.gov/pubmed/33897465 http://dx.doi.org/10.3389/fphys.2021.658790 |
_version_ | 1783681015982587904 |
---|---|
author | Altomare, Claudia Lodrini, Alessandra Maria Milano, Giuseppina Biemmi, Vanessa Lazzarini, Edoardo Bolis, Sara Pernigoni, Nicolò Torre, Eleonora Arici, Martina Ferrandi, Mara Barile, Lucio Rocchetti, Marcella Vassalli, Giuseppe |
author_facet | Altomare, Claudia Lodrini, Alessandra Maria Milano, Giuseppina Biemmi, Vanessa Lazzarini, Edoardo Bolis, Sara Pernigoni, Nicolò Torre, Eleonora Arici, Martina Ferrandi, Mara Barile, Lucio Rocchetti, Marcella Vassalli, Giuseppe |
author_sort | Altomare, Claudia |
collection | PubMed |
description | BACKGROUND: Combined treatment with anthracyclines (e.g., doxorubicin; Dox) and trastuzumab (Trz), a humanized anti-human epidermal growth factor receptor 2 (HER2; ErbB2) antibody, in patients with HER2-positive cancer is limited by cardiotoxicity, as manifested by contractile dysfunction and arrhythmia. The respective roles of the two agents in the cardiotoxicity of the combined therapy are incompletely understood. OBJECTIVE: To assess cardiac performance, T-tubule organization, electrophysiological changes and intracellular Ca(2+) handling in cardiac myocytes (CMs) using an in vivo rat model of Dox/Trz-related cardiotoxicity. METHODS AND RESULTS: Adult rats received 6 doses of either Dox or Trz, or the two agents sequentially. Dox-mediated left ventricular (LV) dysfunction was aggravated by Trz administration. Dox treatment, but not Trz, induced T-tubule disarray. Moreover, Dox, but not Trz monotherapy, induced prolonged action potential duration (APD), increased incidence of delayed afterdepolarizations (DADs) and beat-to-beat variability of repolarization (BVR), and slower Ca(2+) transient decay. Although APD, DADs, BVR and Ca(2+) transient decay recovered over time after the cessation of Dox treatment, subsequent Trz administration exacerbated these abnormalities. Trz, but not Dox, reduced Ca(2+) transient amplitude and SR Ca(2+) content, although only Dox treatment was associated with SERCA downregulation. Finally, Dox treatment increased Ca(2+) spark frequency, resting Ca(2+) waves, sarcoplasmic reticulum (SR) Ca(2+) leak, and long-lasting Ca(2+) release events (so-called Ca(2+) “embers”), partially reproduced by Trz treatment. CONCLUSION: These results suggest that in vivo Dox but not Trz administration causes T-tubule disarray and pronounced changes in electrical activity of CMs. While adaptive changes may account for normal AP shape and reduced DADs late after Dox administration, subsequent Trz administration interferes with such adaptive changes. Intracellular Ca(2+) handling was differently affected by Dox and Trz treatment, leading to SR instability in both cases. These findings illustrate the specific roles of Dox and Trz, and their interactions in cardiotoxicity and arrhythmogenicity. |
format | Online Article Text |
id | pubmed-8058443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80584432021-04-22 Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab Altomare, Claudia Lodrini, Alessandra Maria Milano, Giuseppina Biemmi, Vanessa Lazzarini, Edoardo Bolis, Sara Pernigoni, Nicolò Torre, Eleonora Arici, Martina Ferrandi, Mara Barile, Lucio Rocchetti, Marcella Vassalli, Giuseppe Front Physiol Physiology BACKGROUND: Combined treatment with anthracyclines (e.g., doxorubicin; Dox) and trastuzumab (Trz), a humanized anti-human epidermal growth factor receptor 2 (HER2; ErbB2) antibody, in patients with HER2-positive cancer is limited by cardiotoxicity, as manifested by contractile dysfunction and arrhythmia. The respective roles of the two agents in the cardiotoxicity of the combined therapy are incompletely understood. OBJECTIVE: To assess cardiac performance, T-tubule organization, electrophysiological changes and intracellular Ca(2+) handling in cardiac myocytes (CMs) using an in vivo rat model of Dox/Trz-related cardiotoxicity. METHODS AND RESULTS: Adult rats received 6 doses of either Dox or Trz, or the two agents sequentially. Dox-mediated left ventricular (LV) dysfunction was aggravated by Trz administration. Dox treatment, but not Trz, induced T-tubule disarray. Moreover, Dox, but not Trz monotherapy, induced prolonged action potential duration (APD), increased incidence of delayed afterdepolarizations (DADs) and beat-to-beat variability of repolarization (BVR), and slower Ca(2+) transient decay. Although APD, DADs, BVR and Ca(2+) transient decay recovered over time after the cessation of Dox treatment, subsequent Trz administration exacerbated these abnormalities. Trz, but not Dox, reduced Ca(2+) transient amplitude and SR Ca(2+) content, although only Dox treatment was associated with SERCA downregulation. Finally, Dox treatment increased Ca(2+) spark frequency, resting Ca(2+) waves, sarcoplasmic reticulum (SR) Ca(2+) leak, and long-lasting Ca(2+) release events (so-called Ca(2+) “embers”), partially reproduced by Trz treatment. CONCLUSION: These results suggest that in vivo Dox but not Trz administration causes T-tubule disarray and pronounced changes in electrical activity of CMs. While adaptive changes may account for normal AP shape and reduced DADs late after Dox administration, subsequent Trz administration interferes with such adaptive changes. Intracellular Ca(2+) handling was differently affected by Dox and Trz treatment, leading to SR instability in both cases. These findings illustrate the specific roles of Dox and Trz, and their interactions in cardiotoxicity and arrhythmogenicity. Frontiers Media S.A. 2021-04-07 /pmc/articles/PMC8058443/ /pubmed/33897465 http://dx.doi.org/10.3389/fphys.2021.658790 Text en Copyright © 2021 Altomare, Lodrini, Milano, Biemmi, Lazzarini, Bolis, Pernigoni, Torre, Arici, Ferrandi, Barile, Rocchetti and Vassalli. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Altomare, Claudia Lodrini, Alessandra Maria Milano, Giuseppina Biemmi, Vanessa Lazzarini, Edoardo Bolis, Sara Pernigoni, Nicolò Torre, Eleonora Arici, Martina Ferrandi, Mara Barile, Lucio Rocchetti, Marcella Vassalli, Giuseppe Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab |
title | Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab |
title_full | Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab |
title_fullStr | Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab |
title_full_unstemmed | Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab |
title_short | Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab |
title_sort | structural and electrophysiological changes in a model of cardiotoxicity induced by anthracycline combined with trastuzumab |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058443/ https://www.ncbi.nlm.nih.gov/pubmed/33897465 http://dx.doi.org/10.3389/fphys.2021.658790 |
work_keys_str_mv | AT altomareclaudia structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab AT lodrinialessandramaria structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab AT milanogiuseppina structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab AT biemmivanessa structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab AT lazzariniedoardo structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab AT bolissara structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab AT pernigoninicolo structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab AT torreeleonora structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab AT aricimartina structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab AT ferrandimara structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab AT barilelucio structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab AT rocchettimarcella structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab AT vassalligiuseppe structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab |